BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback